Last reviewed · How we verify

Ivermectin Injectable Product

Barcelona Institute for Global Health · Phase 3 active Small molecule

Ivermectin is a macrocyclic lactone that binds to glutamate-gated chloride channels in parasites and some pathogens, causing paralysis and death.

Ivermectin is a macrocyclic lactone that binds to glutamate-gated chloride channels in parasites and some pathogens, causing paralysis and death. Used for Parasitic infections (onchocerciasis, strongyloidiasis, scabies), Investigational use in COVID-19 and other infectious diseases (phase 3 context suggests expanded indication study).

At a glance

Generic nameIvermectin Injectable Product
Also known asVeterinary Ivermectin 1%
SponsorBarcelona Institute for Global Health
Drug classAntiparasitic agent; macrocyclic lactone
TargetGlutamate-gated chloride channels (GluCl)
ModalitySmall molecule
Therapeutic areaInfectious Disease; Parasitology
PhasePhase 3

Mechanism of action

Ivermectin selectively activates chloride channels in invertebrate nervous and muscular systems, leading to hyperpolarization, paralysis, and death of susceptible organisms. The injectable formulation allows systemic delivery for treatment of parasitic and certain infectious diseases. It has also been investigated for potential antiviral and immunomodulatory properties in various conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results